González GJ, León EF, Espinosas RP

Language: Spanish
References: 16
Page: 46-52
PDF size: 110.10 Kb.

ABSTRACT

Background. bleeding esophageal varicose is the most and dangerous complications in the patient with liver disease plus hypertension portal. Almost 50% of patients with cirrhosis have acute bleeding, 30% occurs during the first 6 -12 months from diagnostic. The portal hypertension complications are ascitis, hepatic encephalopathy and tract digestive hemorrhage. During endoscopic procedure scleroterapy and band ligature are the best treatment option for this patients. Material and methods. From January 2004 to December 2004,.we reviewed all the patients with portal hypertension diagnosis plus esophageal varicose .They had been studied for hepatic transplant. There were 166 patients, 117 females, and 49 males, the esophageal varicose grade were determinate to the Dagradi endoscopy scale: 21 patients type I. 10 type II. 45 type III, 69 type IV, and 21 type V. Sclerosant agent used polidocanol 1.5%, by intravariceal and paravariceal application in 62 patient with esophageal varicose type IV and V and scale child B and C Results. All patients had well outcome during one year after treatment any patient had digestive bleeding, 4 patients development stenosis into lower third esophagus plus pseudodiverticulum, 2 patients development pseudodiverticulums. One patient had severe bleeding during scleroterapy procedure. One patient had minor hemorrhage, two patients had esophagus perforations during dilatations stenosis, Conclutions: endoscopic scleroterapy is well option for the treatment of acute hemorrhagic and it’s prevention in patients with esophageal varicose, It’s complications are minor that surgery complications.

REFERENCES

1. Sociedad Española de Patología Digestiva 2003.Revista de Gastroenterologia del Peru , Volumen 20 No 1 2000

2. Sandblom P. The history of portal hypertension. J R Soc Med 86:544,1993

3. Michael J, Zinner, Seymour I, Schwartz, Maingot , operaciones abdominales , Tomo II, 10 Ed, Edit. panamericana

4. Groszmann RJ .Atterbury CE. The phatophysiology of portal hypertension. Semin Liver Dis 2 : 177 , 1982

5. Meinhard Classen, Gastroenterological Endoscopy, Thieme, 2000, pp 267-270

6. Sleinsger and fordtrand, Enf. Gastrointestinales y hepaticas. 6ª Ed. 2000, tomo 2, pp 1374-1381

7. Garcia- Pagan JC,Bosch J ,Rodes. The Role of vasoactives mediators in portal hipertensión ,semin Gastrointest Dis 6 :140, 1995

8. Hashizume M Sugimachi K .Classification of gastric lesions associated with portal hypertension . J Gastroenterol hepatol 10:339 , 1995

9. Zivak , Gastroenterological Endoscopy 2da Ed. Vol 1 , 2000 vol.1, pp. 362-363

10. Witte CL,Witte MH. Chaos and predicting varix hemorrhage. Med hypoth 36:312, 991

11. Navarro VJ, Garcia – Tsao. Variceal hemorrhage . Crit Care Clin 11: 391, 1995

12. Digestive Diseases self- education Program III. The american gastroenterological Endoscopy , 2003, pp. 41

13. Orozco H, Mercado Ma.Current role of surgery for the treatment of portal hypertension, Ann hepatol 2002 octdec; 1 (4): 175-8

14. Binmoeller Kf, Soehendra N.Nonsurgical treatment of variceal bleeding; new modalites Am J Gastroenterol 1995, Nov 90 (11) : 1923-31

15. Ferguson jw, Tripth D. Hayes PC.the management of acute variceal bleeding aliment pharmacol ther 2003 Aug 1; 18 (3) : 253-62

16. Woods KL, Queresh WA.Long- term endoscopic management of variceal bleeding Gastrointes Endosc. Clin. N Am 1999, Apr 9 (2): 253-70